These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
304 related items for PubMed ID: 19393199
1. Myelin peptides in multiple sclerosis. Grau-López L, Raïch D, Ramo-Tello C, Naranjo-Gómez M, Dàvalos A, Pujol-Borrell R, Borràs FE, Martínez-Cáceres E. Autoimmun Rev; 2009 Jul; 8(8):650-3. PubMed ID: 19393199 [Abstract] [Full Text] [Related]
2. Experimental autoimmune encephalomyelitis mediated by CD8+ T cells. Ji Q, Goverman J. Ann N Y Acad Sci; 2007 Apr; 1103():157-66. PubMed ID: 17376824 [Abstract] [Full Text] [Related]
3. CD4 T-cell epitopes of human alpha B-crystallin. Chou YK, Burrows GG, LaTocha D, Wang C, Subramanian S, Bourdette DN, Vandenbark AA. J Neurosci Res; 2004 Feb 15; 75(4):516-23. PubMed ID: 14743435 [Abstract] [Full Text] [Related]
4. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Genain CP, Cannella B, Hauser SL, Raine CS. Nat Med; 1999 Feb 15; 5(2):170-5. PubMed ID: 9930864 [Abstract] [Full Text] [Related]
5. Induction of EAE by T cells specific for alpha B-crystallin depends on prior viral infection in the CNS. Verbeek R, van Dongen H, Wawrousek EF, Amor S, van Noort JM. Int Immunol; 2007 Mar 15; 19(3):277-85. PubMed ID: 17267417 [Abstract] [Full Text] [Related]
6. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets. Holmøy T. Minerva Med; 2008 Apr 15; 99(2):119-40. PubMed ID: 18431322 [Abstract] [Full Text] [Related]
7. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting. Stinissen P, Raus J. Acta Neurol Belg; 1999 Mar 15; 99(1):65-9. PubMed ID: 10218096 [Abstract] [Full Text] [Related]
10. The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. van Noort JM, van Sechel AC, Bajramovic JJ, el Ouagmiri M, Polman CH, Lassmann H, Ravid R. Nature; 1995 Jun 29; 375(6534):798-801. PubMed ID: 7596414 [Abstract] [Full Text] [Related]
11. The immunological basis for treatment of multiple sclerosis. Holmøy T, Vartdal F. Scand J Immunol; 2007 Oct 29; 66(4):374-82. PubMed ID: 17850581 [Abstract] [Full Text] [Related]
12. Do microbes with peptides mimicking myelin cause multiple sclerosis if the T cell response to their unique peptides is limited? Kaufman MD. J Theor Biol; 1998 Aug 21; 193(4):691-708. PubMed ID: 9745761 [Abstract] [Full Text] [Related]
13. Further studies of the allergic nature of multiple sclerosis and the commencement of therapeutic trials. Campbell B, Vogel PJ, Fisher E, Lorenz R. Trans Am Neurol Assoc; 1970 Aug 21; 95():192-5. PubMed ID: 5514365 [No Abstract] [Full Text] [Related]
14. Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides. Fontoura P, Garren H, Steinman L. Int Rev Immunol; 2005 Aug 21; 24(5-6):415-46. PubMed ID: 16318989 [Abstract] [Full Text] [Related]
15. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). Ziemssen T, Ziemssen F. Autoimmun Rev; 2005 Sep 21; 4(7):460-7. PubMed ID: 16137612 [Abstract] [Full Text] [Related]
16. Induction of experimental autoimmune encephalomyelitis in Lewis rats by a viral peptide with limited homology to myelin basic protein. Mao YS, Lu CZ, Wang X, Xiao BG. Exp Neurol; 2007 Aug 21; 206(2):231-9. PubMed ID: 17617406 [Abstract] [Full Text] [Related]
17. Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis. Harp CT, Lovett-Racke AE, Racke MK, Frohman EM, Monson NL. Clin Immunol; 2008 Sep 21; 128(3):382-91. PubMed ID: 18599355 [Abstract] [Full Text] [Related]
18. Candidate autoantigens in multiple sclerosis. Schmidt S. Mult Scler; 1999 Jun 21; 5(3):147-60. PubMed ID: 10408714 [Abstract] [Full Text] [Related]
19. T-cell vaccination in multiple sclerosis. Achiron A, Mandel M. Autoimmun Rev; 2004 Jan 21; 3(1):25-32. PubMed ID: 14871646 [Abstract] [Full Text] [Related]
20. Type 1 interferons cool the inflamed brain. Axtell RC, Steinman L. Immunity; 2008 May 21; 28(5):600-2. PubMed ID: 18482563 [Abstract] [Full Text] [Related] Page: [Next] [New Search]